All Stories

  1. Reducing Neocarinal Metal Burden in Bifurcation Percutaneous Coronary Intervention With an Intravascular Ultrasound-Guided Double-Kissing Nano-Culotte Technique: A Case Report
  2. Trimetazidine in Heart Failure: From Metabolic Modulation to Clinical Outcomes—A Narrative Review
  3. Efficacy and Safety of Inhaled Treprostinil in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
  4. Overcoming Hyperkalaemia to Optimise Heart Failure Therapy: The Emerging Role of Novel Potassium Binders
  5. Beyond Traditional Lipid Lowering: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition
  6. Aldosterone Synthase Inhibitors: Emerging Therapeutic Strategies in Resistant Hypertension
  7. Borderline Significance or Biological Signal? Reinterpreting the ODYSSEY-HCM Trial in Non-obstructive Hypertrophic Cardiomyopathy
  8. Serum Angiopoietin-1 and Angiopoietin-2 as Biomarkers of Pulmonary Hemodynamic Burden in COPD-Associated Pulmonary Hypertension: A Cross-Sectional Study
  9. Safety and Efficacy of Ticagrelor with Aspirin DAPT vs. Aspirin Alone in Patients Undergoing CABG Following ACS: A Systematic Review and Meta-Analysis
  10. From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease
  11. A study of extended lipid profile in patients with acute coronary syndrome: Focus on Lipoprotein(a) and PCSK9
  12. ``2025 ESC/EAS Dyslipidaemia Guidelines Focused Update: Intensifying Prevention, Risk Stratification, and Therapy"
  13. Dual Pathway Inhibition: Redefining the Secondary Prevention COMPASS in Chronic Coronary Artery Disease
  14. Incidence and predictors of temporary pacemaker implantation–induced cardiac perforation
  15. Recurrent pulmonary embolism with haemoptysis, a challenging case
  16. Intensive Lipid-Lowering Therapy Following Acute Coronary Syndrome: The Earlier the Better
  17. Pivotal Trials in Heart Failure in 2024—Putting Evidence into Clinical Practice!
  18. Interventional Scenario of Cardiology in Uttar Pradesh for 2022–2024 – Insights from Mid-term Intervention Council Meet of Cardiological Society of India, Uttar Pradesh State Chapter
  19. Guideline-Directed Medical Therapy in the Management of Cardiovascular Disease: A Cross-sectional Questionnaire-based Study amongst Indian Healthcare Professionals
  20. Microalbuminuria as an indicator for LVH severity in patients with primary hypertension
  21. Left bundle branch pacing cardiac resynchronization therapy vs biventricular pacing cardiac resynchronization therapy–time to write a requiem for biventricular pacing-cardiac resynchronization therapy
  22. Outcomes of patients with acute ST-segment elevation myocardial infarction treated by a prolonged “Deferred” percutaneous coronary intervention strategy
  23. Direct Oral Anticoagulant Use in Older Adults with Atrial Fibrillation: Challenges and Solutions
  24. Advances in Cardiovascular Multimodality Imaging in Patients with Marfan Syndrome
  25. Uncommon presentation of gastrointestinal tuberculosis-A case series
  26. Feasibility and safety of the 5 Fr Glidesheath Slender in female patients: A randomized controlled trial
  27. Shifting Paradigms in the Management of Pulmonary Hypertension
  28. Evidence for Aldosterone Antagonism in Heart Failure
  29. From the INVICTUS Trial to Current Considerations: It’s Not Time to Retire Vitamin K Inhibitors Yet!
  30. The third-generation anticoagulants: factors XI, XII, and XIII inhibitors
  31. Recurrence rate and predictors in non-ischemic reversible bradyarrhythmias
  32. Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India
  33. EMMY trial: What we know and what we need to know
  34. TRANSFORM-HF Trial: Choice of loop diuretic in acute heart failure does not matter!
  35. High-Density Lipoprotein-Associated Paraoxonase-1 (PON-1) and Scavenger Receptor Class B Type 1 (SRB-1) in Coronary Artery Disease: Correlation with Disease Severity
  36. Comparative analysis of central aortic blood pressure, pulse wave velocity & arterial stiffness in patients with obstructive airway disease
  37. Correlation of lipid profile APO A1 and APO B100 in chronic periodontitis patients leading to coronary artery disease
  38. Rasmussen’s aneurysm: A rare fatal complication in a patient of post-COVID-19 pneumonia with invasive aspergillosis
  39. Torsemide as a Primary Choice in Edema Associated with Heart Failure
  40. EMPULSE trial: Time to use SGLT-2 inhibitors in acute heart failure?
  41. The Year in Cardiology—Practice Changing Trials from European Society of Cardiology Congress 2023
  42. Comparison Between Creatinine-Modified Pugh Score and Child-Pugh Score for Prognostication in Decompensated Cirrhosis
  43. Clopidogrel resistance and its relevance: Current concepts
  44. The unpredictable resorption of bioresorbable scaffolds—A tale of two ABSORBs
  45. Lipid Association of India 2023 update on cardiovascular risk assessment and lipid management in Indian patients: Consensus statement IV
  46. Recent advances in cardiology – Hot trials from the American Heart Association Annual Scientific Meeting 2023
  47. Steroids and pericardial TB: “Friend or Foe”
  48. Predictors of permanent pacemaker implantation following transcatheter aortic valve replacement-the search is still on!
  49. To evaluate the relationship of obstructive sleep apnea with chronic periodontitis and its association with coronary artery disease by assessing serum tumor necrosis factor-α
  50. Reliability of Fractional Flow Reserve in Non-Infarct-Related Arteries in ST-Segment Elevation Myocardial Infarction Patients Undergoing a Pharmaco-Invasive Approach
  51. Assessing the Utility of the DAPT Score and PRECISE‐DAPT Score in Determining the Appropriateness of Dual Antiplatelet Therapy in Patients With Acute Myocardial Infarction/Percutaneous Coronary Intervention
  52. Complete atrioventricular block—an uncommon clinical presentation in an adult patient with proven dengue fever
  53. A Global Perspective on Cardiovascular Risk Factors by Educational Level in CHD Patients: SURF CHD II
  54. Detection of drug-resistant Mycobacterium tuberculosis in pericardial fluid culture and its correlation with cartridge based nucleic acid amplification test and adenosine deaminase activity
  55. Hybrid Pulmonary Sequestration, Cystic Pulmonary Adenomatoid Malformation, and Dextrocardia: A Triple Whammy
  56. The Role of Multimodality Imaging in Patients with Congenital Heart Disease and Infective Endocarditis
  57. Abstract 13569: Impact of Intense Smartphone Application Based versus Routine Outpatient Follow-Up on Short Term Clinical Outcomes in Acute Decompensated Heart Failure (ADHF)
  58. Abstract 18795: Low Density Lipoprotein Cholesterol Levels at Baseline and the Need for Additional Non Statin Lipid Lowering Therapy for Attaining Lipid Targets in Patients Presenting With Acute Coronary Syndromes- A Retrospective Study
  59. A tale of two in stent restenosis in same patient: Surprising findings from optical coherence tomography
  60. Optical Coherence Tomography Findings in Patients Presenting With In-Stent Restenosis: A Prospective Observational Study of Patterns of Neointimal Hyperplasia and Associated Risk Factors
  61. The Role of Multimodality Imaging in Pediatric Cardiomyopathies
  62. Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
  63. Curious case of stent loss managed by a novel escort guiding technique
  64. Feasibility and efficacy of delayed pharmacoinvasive therapy for ST-elevation myocardial infarction
  65. The surprises in optical coherence tomography (OCT) findings in patients presenting with in-stent restenosis: the road less travelled
  66. Anticoagulation for Left Ventricle Thrombus—Case Series and Literature Review for Use of Direct Oral Anticoagulants
  67. Clinical Outcomes of a Non-Compliant Balloon Dilatation Catheter: MOZEC™ NC Study
  68. Lipid Profile and Small Dense Low-Density Lipoprotein in Acute Coronary Syndrome Patients: Relationships to Demographic, Clinical, Angiographic, and Therapeutic Variables
  69. HYBRID PULMONARY SEQUESTRATION, CYSTIC PULMONARY ADENOID MALFORMATION, AND DEXTROCARDIA: A TRIPLE WHAMMY
  70. Intravascular lithotripsy for coronary calcium: A case report and review of the literature
  71. Correlation of lipoprotein (a) levels and plaque morphology in very young acute coronary syndrome patients using optical coherence tomography
  72. Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status
  73. The use of sodium-glucose cotransporter 2 inhibitor in heart failure: The rise of the Roman Empire!
  74. Study of coronary sinus anatomy during levophase of coronary angiography
  75. Prevalence and Clinical Features of Portopulmonary Hypertension in Patients With Hepatic Cirrhosis: An Echocardiographic Study
  76. Evidence for intensive LDL-C lowering for acute coronary syndrome: Recommendations from the Lipid Association of India
  77. Snake in right coronary artery—Extensive spontaneous coronary artery dissection in a young male
  78. Concurrent Coronary, Left Ventricle, and Cerebral Thrombosis – A Trilogy
  79. Management of Dyslipidaemia for the Prevention of Stroke: Clinical Practice Recommendations from the Lipid Association of India
  80. Factors influencing radial artery occlusion after transradial coronary intervention in the Indian population
  81. Instantaneous wave-free ratio and fractional flow reserve: effect of variation in left ventricular end diastolic pressure
  82. Silent giant left atrium: A case report
  83. Evaluation of only heparin-based rota-flush solution against alternative rota-flush solution in patients with severe coronary artery calcification undergoing rotational atherectomy
  84. Spectrum of interstitial lung diseases and their association with pulmonary hypertension
  85. Estimates of Prevalence of Pulmonary Hypertension according to Different International Definitions
  86. Circulating Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1): A Diagnostic Indicator across the Spectrum of Acute Coronary Syndrome
  87. A “20/20” Match: ACC/AHA 2017 versus ESC/ESH 2018 Guidelines for Management of Hypertension
  88. Silent Giant Left Atrium: A Case Report
  89. Coronavirus and cardiovascular manifestations- getting to the heart of the matter
  90. Hydropneumopericardium: A rare complication of pericardiocentesis
  91. Culprit lesion characteristics in very young patients with acute coronary syndrome: An optical coherence tomography study
  92. Recurrent ST-Elevation Myocardial Infarction in a Single Coronary Artery
  93. SILENT GIANT LEFT ATRIUM
  94. Screening for Prevalence of Abdominal Aortic Aneurysm During Transthoracic Echocardiography in Patient With Significant Coronary Artery Disease
  95. Sinus Node Dysfunction and Pulmonary Hypertension—“Double Trouble” with Lithium Therapy
  96. Spectrum of interstitial lung diseases (ILDs) and associated prevalence of pulmonary hypertension
  97. Comparative analysis of central aortic blood pressure, pulse wave velocity, and other indicators of arterial stiffness in patients with obstructive pulmonary diseases in Indian population
  98. Demographic, clinical and etiological profile of pericardial effusion in India: A single centre experience
  99. ‘Routine’ versus ‘Smart Phone Application Based – Intense’ follow up of patients with acute coronary syndrome undergoing percutaneous coronary intervention: Impact on clinical outcomes and patient satisfaction
  100. Small Dense Low-Density Lipoprotein for Risk Prediction of Acute Coronary Syndrome
  101. Cor Triatriatum Dexter with Noncompaction of Right Ventricle and Complete Heart Block: An Unholy Trinity
  102. Isolated ST-Elevation Myocardial Infarction Involving Leads I and aVL: Angiographic and Electrocardiographic Correlations from a Tertiary Care Center
  103. COVID-19 and Cardiovascular Diseases: Challenges and Solutions
  104. Circulating microRNA-126 &122 in patients with coronary artery disease: Correlation with small dense LDL
  105. Deferred Stenting for Heavy Thrombus Burden During Percutaneous Coronary Intervention for ST-Elevation MI
  106. Clinical and Radiological Presentations of Various Pulmonary Infections in Hospitalized Diabetes Mellitus Patients: A Prospective, Hospital-Based, Comparative, Case Series Study
  107. Isolated Spontaneous Mesenteric Artery Dissection: A Rare Entity
  108. Remdesivir – Current evidence & perspective in management of COVID-19 infection
  109. A rare cause of hemoptysis in a young female
  110. Diagnostic Value of Circulating MicroRNAs for Middle Aged Coronary Artery Disease Patients: A Case-control Study
  111. Hydroxychloroquine and COVID-19 – A narrative review
  112. The time to reversal of complete atrioventricular block and its predictors in acute ST-segment elevation myocardial infarction
  113. Novel Dual Therapy: A Paradigm Shift in Anticoagulation in Patients of Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
  114. Differential Effects of Combination of Renin-Angiotensin-Aldosterone System Inhibitors on Central Aortic Blood Pressure: A Cross-Sectional Observational Study in Hypertensive Outpatients
  115. Ezetimibe and Improving Cardiovascular Outcomes: Current Evidence and Perspectives
  116. Proposed low-density lipoprotein cholesterol goals for secondary prevention and familial hypercholesterolemia in India with focus on PCSK9 inhibitor monoclonal antibodies: Expert consensus statement from Lipid Association of India
  117. Triglycerides and Cardiovascular Outcomes—Can We REDUCE-IT ?
  118. Left ventricular strain: A reliable predictor of short-term outcomes in patients with anterior wall myocardial infarction without heart failure
  119. “YoYo” ball in heart: Uncommon cause of dyspnea in an elderly female
  120. Acute myocardial infarction as the initial presentation of behcet's syndrome
  121. Eplerenone: The multifaceted drug in cardiovascular pharmacology
  122. Pulmonary neuroendocrine tumor in a young male
  123. Lasers for the treatment of coronary artery disease: An update
  124. Evaluation of Baseline Hemoglobin Levels and Creatinine Clearance as Independent Prognostic Factors for Patients Undergoing Primary Percutaneous Coronary Intervention
  125. Safety and feasibility of same-day discharge after elective percutaneous balloon mitral valvotomy: a prospective, single-center registry in India
  126. Azilsartan: Current Evidence and Perspectives in Management of Hypertension
  127. To study the usefulness and comparison of myocardial strain imaging by 2D and 3D echocardiography for early detection of cardiotoxicity in patients undergoing cardiotoxic chemotherapy
  128. Clinico-Epidemiological Study of Pericardial Effusion in Northern India
  129. Clinical, Radiological, Microbiological and pulmonary function Spectrum of Post Tubercular Bronchiectasis A Contemporary Study from Tertiary Care Centre
  130. Medical Therapy for Eisenmenger Syndrome: A Case Report and Review of Literature
  131. Stroke Complicating Acute ST Elevation Myocardial Infarction—Current Concepts
  132. Late presentation of anomalous left coronary artery arising from pulmonary artery with acute coronary syndrome
  133. Invasive Assessment of Central Aortic Blood Pressure, Differential Impact of Beta Blocker vs. Non-Beta Blockers and their Correlation with Severity of Coronary Artery Disease in Hypertensive Patients Undergoing Coronary Angiography
  134. PROGNOSIS AND PREDICTORS OF RECURRENCE IN PATIENTS OF REVERSIBLE SYMPTOMATIC BRADYARRYTHMIA: RESULTS FROM AN OBSERVATIONAL STUDY
  135. Post Coronary Artery Bypass Grafting Failure—Don’t Always Blame the Blues!!
  136. Aspirin for primary prevention: The changing paradigms!
  137. Curious case of primary pulmonary mucoepidermoid carcinoma
  138. Prevalence and incidence of hyponatremia and their association with diuretic therapy: Results from North India
  139. Short-Term Clinical Follow-Up After Thrombolytic Therapy in Patients With Prosthetic Valve Thrombosis: A Single-Center Experience
  140. Clinical, demographic and radiological profile of smoker COPD versus nonsmoker COPD patients at a tertiary care center in North India
  141. Fimasartan: A new armament to fight hypertension
  142. Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
  143. An unusual case of isolated right-sided infective endocarditis masquerading as non-resolving pneumonia
  144. “The unpredictable ABSORB” – very late stent thrombosis of bioresorbable vascular scaffold
  145. Oral tuberculosis - Current concepts
  146. Persistent Slow Ventricular Tachycardia following AICD-A Shocking Dilemma!
  147. Curious Case of Myocardial Infarction Caused by Lung Abscess
  148. Optical coherence tomography in in-stent restenosis: A challenge made easier
  149. Concurrent fibrocystic sarcoidosis and tuberculosis: a turmoil
  150. Changing Scenario in Management of Acute Coronary Syndromes in Females—Evidence from Recent Studies
  151. Corrigendum to “Cardiological Society of India position statement on management of heart failure in India” [Indian Heart J 70 (S1) (2018) S1–S72]
  152. Assessment of optimal amount of fluid for the management of hypotension and shock in patients with inferior-wall myocardial infarction, complicated by right ventricular infarction
  153. Natural history of reversible symptomatic bradyarrythmia- An observational study with long term followup
  154. Screening for prevalence of abdominal aortic aneurysm during transthoracic echocardiography in patient with significant coronary artery disease
  155. Diabetes and myocardial infarction: revisiting the conundrum!
  156. Promoter variants of TNF-α rs1800629 and IL-10 rs1800871 are independently associated with the susceptibility of coronary artery disease in north Indian
  157. Acute Pulmonary Thromboembolism in a Patient taking Dabigatran: The Case Report of Possible Dabigatran Resistance
  158. Incidence and predictors of 30-day mortality in patients with ventricular septal rupture complicating acute myocardial infarction
  159. Prosthetic Heart Valves and Pregnancy: Challenges and Solutions
  160. Landmark Trials in Cardiology in 2017—Celebrating 40 Years of Angioplasty
  161. CSI position statement on management of heart failure in India
  162. ‘A snake and a crescent moon in a coronary angiogram’
  163. Clinical and etiological spectrum of prolonged fever and special reference to HIV patients at a tertiary care centre
  164. Syndrome ‘Z’: A Predictor of Angiographic Severity of Coronary Artery Disease in Patients of Acute Coronary Syndrome
  165. Giant posterobasal pseudoaneurysm: An unusual presentation of inferior wall myocardial infarction
  166. TNF-α/IL-10 ratio: An independent predictor for coronary artery disease in North Indian population
  167. ‘Popcorn in the heart’: Thromboemboli in transit during acute pulmonary embolism
  168. Primary tubercular submandibular abscess: a rare presentation in two years old girl
  169. A ping-pong ball in left atrium
  170. Double Trouble in Systemic Sclerosis: Complete Heart Block and Systolic Dysfunction
  171. Spurious ECG changes and simultaneously falsely elevated troponin mimics Acute MI
  172. Correlation between carotid ultrasonography findings and SYNTAX score in South Asian patients with coronary artery disease: A single-center study
  173. Effect of Impaired creatinine clearance on short term outcomes in ACS
  174. Incidence and Outcomes of Early Stent Thrombosis in Patients Receiving Drug-eluting Stents: A Retrospective Study from a Tertiary Care Centre in India
  175. Indigenous technique for difficult cases of balloon mitral valvotomy
  176. Comparison of two LIMA harvesting techniques during CABG
  177. Benefits of Use of Tirofiban in NSTE-ACS
  178. A case of sudden-onset painless unilateral vision loss postintravenous streptokinase in a patient of acute inferior-wall myocardial infarction
  179. Pacemaker lead fracture as a cause of pacing failure
  180. Temporary cardiac pacing induced electrocardiographic changes simulating myocardial infarction
  181. P421Pacing Lead induced pericardial effusion in common but often subcliincal
  182. TCTAP C-123 Roller-coaster PCI of Chronic Total Occlusion in Mid Left Anterior Descending Artery
  183. Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India
  184. Combined Thrombophilia in a Young Male Presenting as Life Threatening Pulmonary Embolism
  185. Decoding the 2017 hypertension guidelines: The ten commandments
  186. Electrocardiogram pearl: ST-T changes in patient with chest pain – Ischemia or infarction?
  187. Association of Vitamin D and essential hypertension in a North Indian population cohort
  188. Giant tubercular pericardial cyst leading to tamponade physiology
  189. Giant coronary arterial aneurysm after drug-eluting stent implantation
  190. TCTAP C-139 Unusual Wire Entrapment with Fracture
  191. Cardiovascular risk screening: Time for a wakeup call!
  192. Chapter-01 Good Clinical Practices in Cath Lab
  193. Metabolic management of heart disease
  194. TCTAP C-137 Longitudinal Compression of Drug Eluting Stent: A Cath Lab. Nightmare!
  195. Three-Dimensional Transthoracic Echocardiograpic Assessment of Pseudoaneurysm of Mitral Aortic Intervalvular Fibrosa: The Benefit of the Added Dimension
  196. Incidental spontaneous coronary dissection: An interventionist′s dilemma
  197. Cleft anterior mitral leaflet with supravalvular aortic stenosis a rare association
  198. A rare case of congenital complex pulmonary AV fistula
  199. Pentology of Fallot's presenting with complete heart block
  200. Renal sympathetic denervation: A promising therapy for resistant hypertension
  201. Noonan Syndrome With Complete Atrioventricular Canal Defect With Pulmonary Stenosis
  202. IVUS guided stenting in moderate looking proximal coronary lesion
  203. Managing heart failure in 2013: Changing paradigms
  204. Management of Coronary Artery Disease in 2013: Recent Insights
  205. Symptomatic complete heart block leading to a diagnosis of Kearns–Sayre syndrome